Case 17

Published on 18/02/2015 by admin

Filed under Allergy and Immunology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1426 times

CASE 17

Edward is 35 years old and has noted some general malaise over the past few months with some weight gain and bloating. He notices his feet, in particular, are quite swollen. When he urinates he has seen some darker tinges to the urine, even when he is clearly not passing concentrated urine (as in the morning). What has finally brought him to the doctor’s office is some bright red sputum he coughed up this morning. He is not, and never has been, a smoker. He has had no recent symptoms suggestive of a respiratory disease and he is currently afebrile. His physician ordered routine blood chemistry, a complete blood cell count with differential, a Mantoux test, and a chest radiograph. Explain the rationale for requesting each of these laboratory tests.

QUESTIONS FOR GROUP DISCUSSION

RECOMMENDED APPROACH

Additional Laboratory Tests

To examine kidney function in more detail, a 24-hour urine collection was ordered to measure creatinine clearance (which is not affected by muscle mass). In effect, this test measures the decrease in serum/blood creatinine over a period of time. When serum creatinine concentration is elevated, one would expect a low clearance rate for creatinine, as this test indicated.

Additionally, an assay of the urine collected indicated that Edward is spilling red blood cells and a considerable amount of protein into the urine (both normally filtered out at the glomerulus and returned to the circulation).

Biopsy and Staining

An antibody-mediated inflammatory reaction at this site will cause the pathophysiology described previously. You should request a biopsy of the relevant affected organs (lung-transbronchial biopsy; renal biopsy) and also staining of tissues (immunofluorescence assay [IFA]) to look for evidence of immunoglobulin deposition. For the IFA, the patient’s serum is deposited on a normal kidney tissue section. To detect autoantibodies that have bound to the tissue, fluorescein-labeled anti-human IgG (or IgA) antibodies are added. Not only is the presence of fluorescein-labeled antibodies diagnostic, but so is the pattern of fluorescence that is observed. If the autoantibodies are bound directly to the tissue (e.g., Goodpasture’s syndrome), a ribbon-like pattern is observed. In contrast, if preformed immune complexes have been deposited in the tissues (e.g., systemic lupus erythematosus [SLE], rheumatoid arthritis [RA]), the pattern will appear to be “lumpy bumpy.”

Staining of Edward’s tissue indicated a ribbon-like (smooth linear) deposit of antibody along the glomerular capillaries (basement membrane), which is consistent with a diagnosis of Goodpasture’s disease. It is important to determine the cause of the pathology, not only because the treatment will be different but also because the longer-term prognosis and course of disease will be very different. The IFA test does not detect specific antibodies, rather it detects any IgG and IgA antibodies that are bound directly to the basement membrane.